Oppenheimer Asset Management
TMDX icon

Oppenheimer Asset Management’s Transmedics TMDX Stock Holding History

Oppenheimer Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,535
Closed -$200K – 1163
2023
Q4 		$200K Buy
+2,535
New +$153K ﹤0.01% 1093

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Oppenheimer Asset Management's TMDX Position: Q1 2024 in Review

Oppenheimer Asset Management sold out of Transmedics (TMDX) in Q1 2024, closing a stake of 2,535 shares — an estimated $200K sold.

Oppenheimer Asset Management first reported a position in TMDX in Q4 2023 and held it in 1 quarter. The position peaked at $200K in Q4 2023. 263 funds tracked by Wall St. Rank hold TMDX as of Q1 2024.

  • Oppenheimer Asset Management reported no remaining Transmedics position as of Q1 2024 after selling out during the quarter.
  • Oppenheimer Asset Management sold 2,535 Transmedics shares in Q1 2024, an estimated $200K.
  • Oppenheimer Asset Management first reported a position in Transmedics in Q4 2023 and held it in 1 quarter.
  • Oppenheimer Asset Management's Transmedics position peaked at $200K in Q4 2023.
  • 263 funds tracked by Wall St. Rank held Transmedics as of Q1 2024.

Based on Oppenheimer Asset Management's 13F filing for Q1 2024, filed 7 May 2024.